Trials / Completed
CompletedNCT07003347
Study to Investigate the Efficacy and Safety of SC0023, in Adults With Refractory or Unexplained Chronic Cough
A Randomized, Double-Blind, Placebo Controlled Cross- Over Study to Investigate the Efficacy and Safety of SC0023, a Magnesium Salt Oral Spray Device, in Adults With Refractory or Unexplained Chronic Cough
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Kholood Altassan · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind, placebo controlled cross-over study to investigate the efficacy and safety of SC0023 (an oral spray of magnesium based alkaline hypertonic divalent salt) in adults with refractory or unexplained chronic cough over 14 days. Approximately 20 participants being enrolled and randomized into the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | oral spray of MgCl2 | Magnesium Salt Oral Spray Device |
| DEVICE | Saline | oral saline aerosol |
Timeline
- Start date
- 2024-12-19
- Primary completion
- 2025-07-30
- Completion
- 2025-08-30
- First posted
- 2025-06-04
- Last updated
- 2026-01-21
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT07003347. Inclusion in this directory is not an endorsement.